Norman Reilly III (Trey) focuses his practice on the representation of issuers and underwriters across a variety of public and private capital markets transactions, including initial public offerings and other equity offerings, high-yield and investment-grade debt offerings, tender offers and more. Trey also regularly advises public companies with respect to compliance with the US securities laws and other corporate governance matters.

Download full bio 

Experience

  • Prelude – $182 Million IPO 

  • Taysha Gene Therapies – $181 Million IPO 

  • Repare Therapeutics - $253 Million IPO 

  • Calliditas Therapeutics - $90 Million IPO 

  • Shake Shack - $215 Million Combined Secondary Offerings 

  • View all

Education

  • Duke University School of Law
    JD, magna cum laude, 2015

  • Fordham University
    BS, Business Administration
    magna cum laude, 2012


Admissions & Credentials

New York